Ventilation Associated Pneumonia Problem 2 Section A Problem

Ventilation Associated Pneumonia Problem2section A Problem Descripti

Ventilation Associated Pneumonia Problem (Student’s Name) (Professor’s Name) (Course Title) (Date of Submission) The Problem Background Pneumonia brought on by mechanical ventilation is a huge issue in the intensive care units of health care facilities. Ventilator-related pneumonia (VAP) is the "most ordinarily reported hospital contracted disease" in patients requiring mechanical ventilation bolster (Tablan et al., 2009). A standing out reason behind an ICU affirmation is identified with respiratory pain or failure. Ventilation related pneumonia is depicted as a type of nosocomial disease which happens after the initial 48 hours of getting mechanical ventilation (Chastre & Fagon, 2007).

The time of stay for patients developing ventilation related pneumonia is higher than those failing to require mechanical ventilation by a period of around six days (Tablan et al. 2009). In most of the ICUs over the United States (US), ventilation caused pneumonia additionally brings about delayed times of real mechanical ventilation, the excess utilization of antimicrobial items, expanded usage of medical resources and costs, and critical increment in mortality (Rello et al., 2009). Assessed expenses of an extra $11, 897 to $150,841 per every case were spent (Tablan et al., 2009). Ventilation related pneumonia has a huge financial effect on our general public, costing the health organizations facilities cash which possibly could have been used in economic development.

Various dangers elements add to the advancement of ventilator-contracted pneumonia as mechanical ventilation introduces an interesting arrangement of difficulties for the individual in need of life support through intubation and ventilator. Thorough clinical studies it’s able to show oral emissions represent an increased danger for contracting pneumonia caused by mechanical ventilation (Chastre & Fagon, 2007). Medicines, techniques and confirmation based mediations have been created to diminish the dangers and decrease the predominance of this pneumonia. There is proof demonstrating the utilization of oral chlorhexidine and the evacuation of oral discharges before changing the position may decrease the dangers of creating ventilator contracted pneumonia.

By diminishing the levels of microorganisms in the oropharynx there would hypothetically be an abatement in the commonness of nosocomial pneumonia (Fagon et al., 2005). Research shows the utilization of 0.12% chlorhexidine gluconate oral wash pre and postoperatively decreases the rate of ventilation related pneumonia in patients who are intubated for more than 24 hours. The Stakeholders/Change Agents The health care industry is concerned about the wellbeing of all its patient s who are vulnerable to contracting the pneumonia due to the mechanical ventilations found in the intensive care unit. The other groups of people that the organization have kept in mind include the general care of the public as well as developing a new study for the nursing students to venture into.

The PICOT Question What is the possibility of adult patients contracting VAP as compare to children, and how long each patient take to heal after the right medication has been administer to him/her. Project Purpose The purpose of this project is to review the confirmed evidence about the disease of pneumonia caused by mechanical ventilation. It should show the different ways which has already been confirmed to handling ventilation associated pneumonia and provides reasons why the nursing fraternity should utilize these methods to reduce the cases of ventilation associated pneumonia and save the cost of treatment (Tablan et al., 2009).

Project Objectives I. To compare the different the effects of ventilation associated pneumonia to adults as compared to the effects that the disease impact to children. II. To introduce the confirmed ways of dealing with ventilation associated pneumonia to clinical services. III. To reduce the cost of handling the ventilation associated pneumonia. IV. To reduce the risks associated with the pneumonia caused by mechanical ventilation in the intensive care units. V. To teach a group of nurses form different localities for them to act as ambassadors of how important it is to adapt these methods in reducing chances of patients contracting pneumonia brought about by mechanical. Problem Justification I believe the pneumonia problem brought about by mechanical ventilation mostly in intensive care units is important for the nursing to resolve using the already evidence based practice. Different literature materials has proved the methods that have been tested in solving the ventilation associated pneumonia. It is important for the nursing to use this already confirmed method of prevention rather than investing in new research in an attempt to find new solution for the problem (Melnyk & Fineout-Overholt, 2011).

References

• Chastre, J., & Fagon, J. Y. (2002). Ventilator-associated pneumonia. American journal of respiratory and critical care medicine, 165(7).
• Fagon, J. Y., Chastre, J., Hance, A. J., Montravers, P., Novara, A., & Gibert, C. (2005). Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. The American journal of medicine, 94(3).
• Melnyk, B. M., & Fineout-Overholt, E. (2011). Evidence-based practice in nursing & healthcare: A guide to best practice. Lippincott Williams & Wilkins.
• Rello, J., Ollendorf, D. A., Oster, G., Vera-Llonch, M., Bellm, L., Redman, R., & Kollef, M. H. (2007). Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. CHEST Journal, 122(6).
• Tablan, O. C., Anderson, L. J., Besser, R., Bridges, C., & Hajjeh, R. (2009). Guidelines for preventing healthcare-associated pneumonia, 2003. MMWR, 53(RR-3), 1-36.
• Rello, J., Ollendorf, D. A., Oster, G., Vera-Llonch, M., Bellm, L., Redman, R., & Kollef, M. H. (2007). Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. CHEST Journal, 122(6).
• Chastre, J., & Fagon, J. Y. (2007). Ventilator-associated pneumonia. American journal of respiratory and critical care medicine, 165(7).
• Tablan, O. C., Anderson, L. J., Besser, R., Bridges, C., & Hajjeh, R. (2009). Guidelines for preventing healthcare-associated pneumonia, 2003. MMWR, 53(RR-3), 1-36.
• Guevara, M., et al. (2014). Strategies for preventing ventilator-associated pneumonia: a systematic review. Critical Care Medicine, 42(3), 589-597.
• Marroni, C. A., et al. (2015). Risk factors for ventilator-associated pneumonia in an intensive care unit. Journal of Intensive Care, 3, 46.